THROMBOLYTIC THERAPY - BASIC AND THERAPEUTIC CONSIDERATIONS

被引:50
作者
SAWYER, WD
ALKJAERSIG, N
FLETCHER, AP
SHERRY, S
机构
关键词
D O I
10.1001/archinte.1961.03620020124014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:274 / &
相关论文
共 57 条
[51]   STUDIES ON PLATELETS .14. HUMAN PLATELETS AS SOURCE OF ANTIFIBRINOLYSIN [J].
STEFANINI, M ;
MURPHY, IS .
JOURNAL OF CLINICAL INVESTIGATION, 1956, 35 (04) :355-361
[52]   THE EFFECT IN PATIENTS OF STREPTOCOCCAL FIBRINOLYSIN (STREPTOKINASE) AND STREPTOCOCCAL DESOXYRIBONUCLEASE ON FIBRINOUS, PURULENT, AND SANGUINOUS PLEURAL EXUDATIONS [J].
TILLETT, WS ;
SHERRY, S .
JOURNAL OF CLINICAL INVESTIGATION, 1949, 28 (01) :173-190
[53]   INTRAVENOUS INFUSION OF THE STREPTOCOCCAL FIBRINOLYTIC PRINCIPLE (STREPTOKINASE) INTO PATIENTS [J].
TILLETT, WS ;
JOHNSON, AJ ;
MCCARTY, WR .
JOURNAL OF CLINICAL INVESTIGATION, 1955, 34 (02) :169-185
[54]   NATURE OF THE THROMBIN-INHIBITING EFFECT OF INCUBATED FIBRINOGEN [J].
TRIANTAPHYLLOPOULOS, DC .
AMERICAN JOURNAL OF PHYSIOLOGY, 1959, 197 (03) :575-579
[55]  
TROLL W, 1954, J BIOL CHEM, V208, P85
[56]   INTRAVENOUS PROTEIN-FREE PYROGEN - A POWERFUL FIBRINOLYTIC AGENT IN MAN [J].
VONKAULLA, KN .
CIRCULATION, 1958, 17 (02) :187-198
[57]  
WEINER M, 1958, P SOC EXP BIOL MED, V98, P755, DOI 10.3181/00379727-98-24174